JDD HighlightsSkin of Color

View the Latest Skin of Color, Anti-Aging, Aesthetic, and Medical Dermatology Articles Now

By June 30, 2020July 9th, 2020No Comments

Dermatology News

JDD Highlights

The July issue of the Journal of Drugs in Dermatology is available now. This month, we focus on Skin of Color, with special features on Anti-Aging, Aesthetic, and Medical Dermatology.
Read the JDD Now

Skin of Color, Anti-Aging, Aesthetic, and Medical Dermatology

The July issue of the Journal of Drugs in Dermatology is available now. This month, we focus on Skin of Color, with special features on Anti-Aging, Aesthetic, and Medical Dermatology.

Article Highlights

Editor's Picks

You May Also Like

Journal of Drugs in Dermatology JDD Article About Keeping You at the Forefront: a message from Dr. Sarnoff, editor in chief of JDD.

Keeping You at the Forefront

| Latest News | No Comments
A Message From the Editor-in-Chief Dear Colleagues, The March issue of the Journal of Drugs in Dermatology highlights a diverse range of topics that reflect our specialty's dynamic and evolving…
Journal of Drugs in Dermatology JDD Article About Social Media's Impact on Hair Loss Information Dissemination: A Systematic Review. Image from the Full Spectrum of Dermatology: A Diverse and Inclusive Atlas. Alopecia image of skin of color range from Inclusive Derm Atlas Online Gallery

Social Media’s Impact on Hair Loss Information Dissemination: A Systematic Review

| Alopecia, Featured Articles | No Comments
Did You Miss It? In December JDD posted a March article early online. If you have not read it yet, you do not want to miss it! Social media is…

Acetyl dipeptide-31 Amide: A Novel Anti-inflammatory Peptide That Demonstrates Anti-Aging, Firming, and Lifting Benefits.

| Featured Articles, The Latest, Video Abstract | No Comments
Featured Video Abstract Check out our all new video abstract from Patricia K. Farris, MD, where she discusses acetyl dipeptide-31 amide as a novel cosmetic anti-inflammatory peptide that demonstrates anti-aging,…

Leave a Reply